Saturday, August 8, 2026

Lupin launches generic hypertension drug in US after regulatory nod

Date:

Lupin has launched Azilsartan Medoxomil tablets in the US after securing FDA approval, becoming the exclusive first-to-file generic applicant and gaining 180 days of market exclusivity for the hypertension treatment.

2 Min Read

Impact Shorts

CNBCTV18 on Google
Lupin launches generic hypertension drug in US after regulatory nod

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

India’s differences with US must be managed through firm negotiation, says Global Trade Research Institute

The US Senate has overwhelmingly approved legislation that could...

BRICS Trade Ministers meet agrees to close global trade finance gap of $2.5 trillion for MSMEs

The 16th BRICS Trade Ministers' Meeting 2026 concluded in...

PFRDA aims to raise non-govt NPS subscriber base to 35-40 crore in 5 years

Pension Fund Regulatory and Development Authority (PFRDA) on Friday...

Goldman Sachs, CLSA split on RBI rate outlook as inflation, growth debate heats up

Goldman Sachs Chief India Economist Santanu Sengupta and CLSA...